Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Search by expertise, name or affiliation
Prot #FF21101US101: A Phase 1 Dose-escalation Study of Radio-labeled Antibody, FF-21101(90Y) for the Treatment of Advanced Cancer
Mahalingam, Devalingam
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
9/14/19
→
9/14/22
Funding
Translational Drug Development, LLC
(Prot #FF21101US101)
FUJIFILM Pharmaceuticals U.S.A., Inc.
(Prot #FF21101US101)
View all
View less